Efficacy and safety of dopamine agonists in traumatic brain injury: A systematic review of randomized controlled trials

Journal of Neurotrauma

Volumn 29, Issue 1, 2012, Pages 1-18

  Frenette, Anne Julie ^a   Kanji, Salmaan ^b   Rees, Laura ^c   Williamson, David R ^a   Perreault, Marc M ^d   Turgeon, Alexis F ^e   Bernard, Francis ^a   Fergusson, Dean A ^b  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

adult brain injury; dopamine agonists; traumatic brain injury

Indexed keywords

AMANTADINE; BROMOCRIPTINE; METHYLPHENIDATE; PLACEBO;

ANOREXIA; ANXIETY; BLURRED VISION; COGNITION; COGNITIVE REHABILITATION; CONFUSION; CONSTIPATION; DELIRIUM; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; HALLUCINATION; HEADACHE; HEMODYNAMICS; HUMAN; IRRITABILITY; MEMORY; MICTURITION DISORDER; NAUSEA; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; TREMOR; UNSPECIFIED SIDE EFFECT; VOMITING; WEAKNESS; XEROSTOMIA;

BRAIN INJURIES; DOPAMINE AGONISTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84856453100     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.1812     Document Type: Review

References (63)

1. Alban, J.P., Hopson, M.M., Ly, V., and Whyte, J. (2004). Effect of methylphenidate on vital signs and adverse effects in adults with traumatic brain injury. Am. J. Phys. Med. Rehabil. 83, 131-137.
2. Ampuero, E., Rubio, F.J., Falcon, R., Sandoval, M., Diaz-Veliz, G., Gonzalez, R.E., Earle, N., Dagnino-Subiabre, A., Aboitiz, F., Orrego, F., and Wyneken, U. (2010). Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex. Neu-roscience 169, 98-108.
3. Bagiella, E., Novack, T.A., Ansel, B., Diaz-Arrastia, R., Dikmen, S., Hart, T., and Temkin, N. (2010). Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network. J. Head Trauma Rehabil. 25, 375-382.
4. Bales, J.W., Wagner, A.K., Kline, A.E., and Dixon, C.E. (2009). Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci. Biobehav. Rev. 33, 981-1003.
5. Barone, P., Palma, V., de Bartolomeis, A., Cicarelli, G., and Campanella, G. (1992). Dopaminergic regulation of epileptic activity. Neurochem. Int. 20 Suppl., 245S-249S.
6. Beers, S.R., Skold, A., Dixon, C.E., and Adelson, P.D. (2005). Neurobehavioral effects of amantadine after pediatric trau-matic brain injury: a preliminary report. J. Head Trauma Re-habil. 20, 450-463. (Pubitemid 41356270)
7. Bruck, A, Portin, R., Lindell, A., Laihinen, A., Bergman, J., Haa-paranta, M., Solin, O., and Rinne, J.O. (2001). Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci. Lett. 311, 81-84. (Pubitemid 32900610)
8. Burruss, J.W., Hurley, R.A., Taber, K.H., Rauch, R.A., Norton, R.E., and Hayman, L.A. (2000). Functional neuroanatomy of the frontal lobe circuits. Radiology 214, 227-230. (Pubitemid 30019897)
9. Corrigan, J.D., Selassie, A.W., and Orman, J.A. (2010). The epi-demiology of traumatic brain injury. J. Head Trauma Rehabil. 25, 72-80.
10. Duchesne, N., Soucy, J.P., Masson, H., Chouinard, S., and Be-dard, M.A. (2002). Cognitive deficits and striatal dopaminer-gic denervation in Parkinson's disease: a single photon emission computed tomography study using 123iodine-beta-CIT in patients on and off levodopa. Clin. Neuropharmacol. 25, 216-224. (Pubitemid 34832762)
11. Falo, M.C., Fillmore, H.L., Reeves, T.M., and Phillips, L.L. (2006). Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J. Neurosci. Res. 84, 768-781. (Pubitemid 44366678)
12. Fleminger, S., Greenwook, R.J., and Oliver, D.L. (2006). Phar-macological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst. Rev. 18, CD003299.
13. Fleminger, S. (2008). Long-term psychiatric disorders after traumatic brain injury. Eur. J. Anaesthesiol. Suppl. 42, 123-130. (Pubitemid 351643051)
14. Francisco, G.E., Walker, W.C., Zasler, N.D., and Bouffard, M.H. (2007). Pharmacological management of neurobehavioural sequelae of traumatic brain injury: a survey of current phy-siatric practice. Brain Inj. 21, 1007-1014. (Pubitemid 47487809)
15. Green, R.E., Colella, B., Hebert, D.A., Bayley, M., Kang, H.S., Till, C., and Monette, G. (2008). Prediction of return to pro-ductivity after severe traumatic brain injury: Investigations of optimal neuropsychological tests and timing of assessment. Arch. Phys. Med. Rehabil. 89, S51-S60.
16. Gualtieri, C.T., and Evans, R.W. (1988). Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj. 2, 273-290.
17. Gualtieri, C.T. (1988). Pharmacotherapy and the neurobeha-vioural sequelae of traumatic brain injury. Brain Inj. 2, 101-129.
18. Heilman, K.M., Voeller, K.K., and Nadeau, S.E. (1991). A pos-sible pathophysiologic substrate of attention deficit hyperac-tivity disorder. J. Child Neurol. 6 Suppl. S76-S81.
19. Higgins, J., and Altman, D. (2008). Assessing risk of bias in in-cluded studies, in: Cochrane Handbook for Systematic Reviews of Interventions. J.P.T. Higgins and S. Green (eds). The Cochrane Collaboration, Version 5.0.1. Available from www.cochrane-handbook.org.
20. Higgins, J., Deeks, J., and Altman, D. (2008). Special topics in statistics, in: Cochrane Handbook for Systematic Reviews of In-terventions. J.P.T. Higgins and S. Green (eds). The Cochrane Collaboration, Version 5.0.1. Available from www.cochrane-handbook.org.
21. Kim, Y.H., Ko, M.H., Na, S.Y., Park, S.H., and Kim, K.W. (2006). Effects of single-dose methylphenidate on cognitive perfor-mance in patients with traumatic brain injury: a double-blind placebo-controlled study. Clin. Rehabil. 20, 24-30.
22. Lammi, M.H., Smith, V.H., Tate, R.L., and Taylor, C.M. (2005). The minimally conscious state and recovery potential: a fol-low-up study 2 to 5 years after traumatic brain injury. Arch. Phys. Med. Rehabil. 86, 746-754. (Pubitemid 40487842)
23. Larson, E.B., and Zollman, F.S. (2010). The effect of sleep med-ications on cognitive recovery from traumatic brain injury. J. Head Trauma Rehabil. 25, 61-67.
24. Lee, H., Kim, S.W., Kim, J.M., Shin, I.S., Yang, S.J., and Yoon, J.S. (2005). Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with trau-matic brain injury. Hum. Psychopharmacol. 20, 97-104.
25. Lefebvre, C., Manheimer, E., and Glanville, J. (2009). Searching for studies, in: Cochrane Handbook for Systematic Reviews of In-terventions. J.P.T. Higgins and S. Green (eds). The Cochrane Collaboration, Version 5.0.2. Available from www.cochrane-handbook.org.
26. Loke, Y., Price, D., and Herxheimer, A. (2008). Adverse effects, in: Cochrane Handbook for Systematic Review of Interventions. J.P.T. Higgins and S. Green (eds). The Cochrane Collabora-tion, Version 5.0.1. Available from www.cochrane-hand-book.org.
27. Maas, A.I., Marmarou, A., Murray, G.D., and Steyerberg, E.W. (2004). Clinical trials in traumatic brain injury: current prob-lems and future solutions. Acta Neurochir. Suppl. 89,113-118.
28. Maas, A.I., Steyerberg, E.W., Marmarou, A., McHugh, G.S., Lingsma, H.F., Butcher, I., Lu, J., Weir, J., Roozenbeek, B., and Murray, G.D. (2010). IMPACT recommendations for improv-ing the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics 7, 127-134.
29. Mahalick, D.M., Carmel, P.W., Greenberg, J.P., Molofsky, W., Brown, J.A., Heary, R.F., Marks, D., Zampella, E., Hodosh, R., and von der Schmidt, E., 3rd. (1998). Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatr. Neurosurg. 29, 121-126. (Pubitemid 28554945)
30. McCauley, S.R., Wilde, E.A., Anderson, V.A., Bedell, G., Beers, S.R., Campbell, T.F., Chapman, S.B., Ewing-Cobbs, L., Ger-ring, J., Gioia, G.A., Levin, H., Michaud, L., Prasad, M.R., Swaine, B., Turkstra, L.A., Wade, S.L., and Yeates, K.O. (2011). Recommendations for the use of common outcome measures in pediatric traumatic brain injury research. J. Neurotrauma [Epub ahead of print].
31. McDowell, S., Whyte, J., and D'Esposito, M. (1998). Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 121 (Pt. 6), 1155-1164. (Pubitemid 28256988)
32. McMahon, M.A., Vargus-Adams, J.N., Michaud, L.J., and Bean, J. (2009). Effects of amantadine in children with impaired consciousness caused by acquired brain injury: a pilot study. Am. J. Phys. Med. Rehabil. 88, 525-532.
33. Meintzschel, F., and Ziemann, U. (2006). Modification of prac-tice-dependent plasticity in human motor cortex by neuro-modulators. Cereb. Cortex 16, 1106-1115. (Pubitemid 44025380)
34. Meythaler, J.M., Brunner, R.C., Johnson, A., and Novack, T.A. (2002). Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J. Head Trauma Rehabil. 17, 300-313. (Pubitemid 34809595)
35. Moein, H., Khalili, H.A., and Keramatian, K. (2006). Effect of methylphenidate on ICU and hospital length of stay in pa-tients with severe and moderate traumatic brain injury. Clin. Neurol. Neurosurg. 108, 539-542. (Pubitemid 44189092)
36. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D.G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535.
37. Mooney, G.F., and Haas, L.J. (1993). Effect of methylphenidate on brain injury-related anger. Arch. Phys. Med. Rehabil. 74, 153-160. (Pubitemid 23059300)
38. Nieoullon, A. (2002). Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67, 53-83. (Pubitemid 34786170)
39. Patry, B.N., and Mateer, C.A. (2006). Neuropsychological as-sessment of moderate to severe traumatic brain injury, in: Psychological Knowledge in Court. G. Young, K. Nicholson, and A.W. Kane (eds). Springer: New York, pps. 352-377
40. Plenger, P.M., Dixon, C.E., Castillo, R.M., Frankowski, R.F., Yablon, S.A., and Levin, H.S. (1996). Subacute methylpheni-date treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch. Phys. Med. Rehabil. 77, 536-540. (Pubitemid 26180922)
41. Ruttan, L., Martin, K., Liu, A., Colella, B., and Green, R.E. (2008). Long-term cognitive outcome in moderate to severe traumatic brain injury: A meta-analysis examining timed and untimed tests at 1 and 4.5 or more years after injury. Arch. Phys. Med. Rehabil. 89, S69-S76.
42. Saatman, K.E., Duhaime, A.C., Bullock, R., Maas, A.I., Valadka, A., and Manley, G.T. (2008). Classification of traumatic brain injury for targeted therapies. J. Neurotrauma 25, 719-738.
43. Schneider, W.N., Drew-Cates, J., Wong, T.M., and Dombovy, M.L. (1999). Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind place-bo-controlled study. Brain Inj. 13, 863-872. (Pubitemid 29504956)
44. Scottish Intercollegiate Guidelines Network. Search filters, in: Scottish Intercollegiate Guidelines Network. Retrieved No-vember 2009 from http://www.sign.ac.uk/methodology/fil-ters.html#random
45. Shukla, D., Devi, B.I., and Agrawal, A. (2011). Outcome mea-sures for traumatic brain injury. Clin. Neurol. Neurosurg. 113, 435-441.
46. Siddall, O.M. (2005). Use of methylphenidate in traumatic brain injury. Ann. Pharmacother. 39, 1309-1313. (Pubitemid 40943185)
47. Sivan, M., Neumann, V., Kent, R., Stroud, A., and Bhakta, B.B. (2010). Pharmacotherapy for treatment of attention deficits after non-progressive acquired brain injury. A systematic re-view. Clin. Rehabil. 24, 110-121.
48. Speech, T.J., Rao, S.M., Osmon, D.C., and Sperry, L.T. (1993). A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj. 7, 333-338. (Pubitemid 23218380)
49. Stern, Y., Tetrud, J.W., Martin, W.R., Kutner, S.J., and Langston, J.W. (1990). Cognitive change following MPTP exposure. Neurology 40, 261-264. (Pubitemid 20099435)
50. Tanaka, S. (2006). Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics per-spective. Neuroscience 139, 153-171.
51. Tenovuo, O. (2006). Pharmacological enhancement of cognitive and behavioral deficits after traumatic brain injury. Curr. Opin. Neurol. 19, 528-533. (Pubitemid 44760434)
52. Thobois, S., Vingerhoets, F., Fraix, V., Xie-Brustolin, J., Mollion, H., Costes, N., Mertens, P., Benabid, A.L., Pollak, P., and Broussolle, E. (2004). Role of dopaminergic treatment in do-pamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study. Arch. Neurol. 61, 1705-1709. (Pubitemid 39463429)
53. Thurman, D., and Guerrero, J. (1999). Trends in hospitalization associated with traumatic brain injury. JAMA 282, 954-957. (Pubitemid 29420314)
54. Tsaousides, T., and Gordon, W.A. (2009). Cognitive rehabilita-tion following traumatic brain injury: Assessment to treat-ment. Mt. Sinai J. Med. 76, 173-181.
55. Whyte, J., Hart, T., Schuster, K., Fleming, M., Polansky, M., and Coslett, H.B. (1997). Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. Am. J. Phys. Med. Rehabil. 76, 440-450.
56. Whyte, J., Hart, T., Vaccaro, M., Grieb-Neff, P., Risser, A., Po-lansky, M., and Coslett, H.B. (2004). Effects of methylpheni-date on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am. J. Phys. Med. Rehabil. 83, 401-420. (Pubitemid 38658128)
57. Whyte, J., Vaccaro, M., Grieb-Neff, P., Hart, T., Polansky, M., and Coslett, H.B. (2008). The effects of bromocriptine on at-tention deficits after traumatic brain injury: a placebo-con-trolled pilot study. Am. J. Phys. Med. Rehabil. 87, 85-99.
58. Wilde, E.A., Whiteneck, G.G., Bogner, J., Bushnik, T., Cifu, D.X., Dikmen, S., French, L., Giacino, J.T., Hart, T., Malec, J.F., Millis, S.R., Novack, T.A., Sherer, M., Tulsky, D.S., Vanderploeg, R.D., and von Steinbuechel. N. (2010). Recommendations for the use of common outcome measures in traumatic brain injury re-search. Arch. Phys. Med. Rehabil. 91, 1650-1660.
59. Williams, S.E., Ris, M.D., Ayyangar, R., Schefft, B.K., and Berch, D. (1998). Recovery in pediatric brain injury: is psychostimu-lant medication beneficial? J. Head Trauma Rehabil. 13, 73-81. (Pubitemid 28301593)
60. Willmott, C., and Ponsford, J. (2009). Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain in-jury: a randomised, crossover, double blind, placebo controlled inpatient trial. J. Neurol. Neurosurg. Psychiatry 80, 552-557
61. Willmott, C., Ponsford, J., Olver, J., and Ponsford, M. (2009). Safety of methylphenidate following traumatic brain injury: impact on vital signs and side-effects during inpatient reha-bilitation. J. Rehabil. Med. 41, 585-587.
62. Wood, L.D. (2010). Clinical review and treatment of select ad-verse effects of dopamine receptor agonists in Parkinson's disease. Drugs Aging 27, 295-310.
63. Writer, B.W., and Schillerstrom, J.E. (2009). Psychopharmacolo-gical treatment for cognitive impairment in survivors of traumatic brain injury: a critical review. J. Neuropsychiatry Clin. Neurosci. 21, 362-370.